We support pharmaceutical, biotech, and diagnostic companies in accelerating the development of precision antimicrobials and advanced detection tools. Our platform enables faster phage candidate identification, biomarker-driven matching, and in silico phage engineering—bridging preclinical insights with real-world clinical demand. By partnering with us, companies can streamline development, expand therapeutic pipelines, and respond to the growing need for effective alternatives to antibiotics.